Skip to main content
A

ALGORAE PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · 1AI ISIN · AU0000296022 ASX Professional, scientific and technical activities
Filings indexed 1,153 across all filing types
Latest filing 2026-03-12 Regulatory Filings
Country AU Australia
Listing ASX 1AI

About ALGORAE PHARMACEUTICALS LIMITED

https://algoraepharma.com/

Algorae Pharmaceuticals Limited is a biopharmaceutical company focused on the discovery and development of novel therapeutic solutions for complex medical conditions. The company leverages its proprietary artificial intelligence platform, AlgoraeOS, to streamline the drug discovery process and identify synergistic drug combinations. Its research pipeline primarily targets neurodegenerative diseases and other areas of high unmet clinical need. Key development programs include AI-116, a combination therapy aimed at treating dementia and Alzheimer's disease. By integrating advanced computational modeling with traditional pharmacological research, the company seeks to accelerate the transition of candidates from preclinical stages to clinical trials, optimizing therapeutic efficacy and safety profiles.

Recent filings

Filing Released Lang Actions
Cleansing Notice 1 page 145.2KB
Regulatory Filings
2026-03-12 English
Final Director's Interest Notice 2 pages 276.0KB
Regulatory Filings
2026-03-11 English
Initial Director's Interest Notice 2 pages 293.2KB
Regulatory Filings
2026-03-11 English
Algorae appoints Mr David Gulland to its Board of Directors 3 pages 204.2KB
Regulatory Filings
2026-03-09 English
Application for quotation of securities - 1AI 7 pages 21.0KB
Regulatory Filings
2026-03-04 English
Cleansing Notice 1 page 145.2KB
Regulatory Filings
2026-03-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.